SUBSCRIBE

Is switching to biosimilar infliximab safe?

 Posted 14/06/2019

Building on a number of studies on biosimilar infliximab for inflammatory bowel disease (IBD), a recent review shows switching to CT-P13 is safe, but more ev...

more
Trastuzumab biosimilar from Prestige accepted f... Biosimilars/News | Posted 14/06/2019
Eli Lilly launches lower-priced insulin lispro Biosimilars/General | Posted 14/06/2019
Brazilian approval for trastuzumab follow-on bi... Biosimilars/News | Posted 14/06/2019
Comments on FDA’s plans to transition insulin p... Guidelines | Posted 14/06/2019
UnitedHealthcare to prefer brand-name pegfilgra... Biosimilars/General | Posted 14/06/2019
Sandoz’s rosuvastatin approved under China’s ne... Biosimilars/News | Posted 14/06/2019
Bulgaria and Cyprus added to EU-US mutual recog... Policies & Legislation | Posted 14/06/2019
Biosimilars to replace older biologicals for IBD Biosimilars/Research | Posted 07/06/2019
Trastuzumab biosimilar Ogivri approved in Canada Biosimilars/News | Posted 07/06/2019
Switching V19A17
Irish hospitals to get incentives to switch pat... Biosimilars/General | Posted 07/06/2019
Brazilian approval for trastuzumab follow-on bi... Biosimilars/News | Posted 07/06/2019
Dramatic price reduction of trastuzumab in Mala... Biosimilars/General | Posted 07/06/2019
US considering eight years protection for biolo... Policies & Legislation | Posted 07/06/2019
Sandoz and EirGenix make deal for trastuzumab b... Pharma News | Posted 07/06/2019
Pharmacy benefit managers use spread pricing to... Generics/General | Posted 07/06/2019
FDA issues guidance on quality-related consider... Guidelines | Posted 31/05/2019
16704526_l
Factors contributing to long-term sustainabilit... Reports | Posted 31/05/2019
FDA’s Orange and Purple Books to be improved an... Policies & Legislation | Posted 31/05/2019
NeuClone to start phase I trial for ustekinumab... Biosimilars/News | Posted 31/05/2019
Settlement for Udenyca and win for Zarxio Biosimilars/General | Posted 31/05/2019
Positive results for rituximab copy biological... Biosimilars/Research | Posted 31/05/2019
Biocon/Mylan gain global rights to adalimumab b... Biosimilars/General | Posted 31/05/2019
Teva launches generic testosterone gel and over... Generics/News | Posted 31/05/2019
GaBI J 2012-1 Cover V12b13PA
GaBI Journal is the number one journal publishi... Biosimilars/Research | Posted 24/05/2019
The level of biosimilars competition in Europe... Reports | Posted 24/05/2019
Stakeholders question FDA’s guidance on naming... Guidelines | Posted 24/05/2019
New biosimilar guide for pharmacists in Australia Policies & Legislation | Posted 24/05/2019
Recommendations published by Canadian breast ca... Biosimilars/General | Posted 24/05/2019
Russian approval for non-originator eculizumab Biosimilars/News | Posted 24/05/2019
BiosanaPharma starts phase I trial for omalizum... Biosimilars/Research | Posted 24/05/2019
Adherence to generic versus brand-name statins... Generics/Research | Posted 24/05/2019
Interchangeability V18K30
FDA issues final guidance on interchangeable bi... Guidelines | Posted 17/05/2019
ST002293
Biosimilars market and opportunities in Europe Reports | Posted 17/05/2019
Canadian organizations collaborate to improve b... Biosimilars/General | Posted 17/05/2019
Multi-state lawsuit alleges widespread generic... Generics/General | Posted 17/05/2019
Adalimumab biosimilar Idacio launched in Germany Biosimilars/News | Posted 17/05/2019
ASCO/ASH give recommendations for biosimilar ESAs Biosimilars/Research | Posted 17/05/2019
EMA approves hypertension and Parkinson’s generics Generics/News | Posted 17/05/2019
20893354_l
Alvotech signs agreement for ustekinumab biosim... Pharma News | Posted 17/05/2019
SMi 10th Annual Biosimilars and Biologics Confe... Conferences | Posted 17/05/2019
Biosimilars education still needed for US and E... Biosimilars/Research | Posted 10/05/2019
EMA approval for pegfilgrastim biosimilar Grasu... Biosimilars/News | Posted 10/05/2019
Automatic pharmacist substitution of biosimilar... Policies & Legislation | Posted 10/05/2019
Patient and provider views on biosimilars to tr... Biosimilars/General | Posted 10/05/2019
Challenges for biosimilar sustainability in Europe Reports | Posted 10/05/2019
FDA pledges to improve quality of compounded drugs Guidelines | Posted 10/05/2019
Pharmacokinetic assessment of biosimilar therap... Biosimilars/Research | Posted 10/05/2019
Alteogen gains patent on SC trastuzumab biosimilar Pharma News | Posted 10/05/2019
FDA approves etanercept biosimilar Eticovo Biosimilars/News | Posted 03/05/2019
more

NON-BIOLOGICAL COMPLEX DRUGS

FDA issues final guidance on liposome drug products Posted 27/04/2018

On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft...

more


FDA approves 40 mg follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 09/03/2018
Mylan launches first follow-on glatiramer aceta... Non‐Biological Complex Drugs/News | Posted 15/02/2018
Biosimilars and follow-on NBCDs for MS in Europ... Non‐Biological Complex Drugs/Research | Posted 19/01/2018
Impax announces FDA approval of follow-on sevel... Non‐Biological Complex Drugs/News | Posted 17/11/2017
FDA approves follow-on version of sevelamer Non‐Biological Complex Drugs/News | Posted 30/06/2017
Challenges in the regulation of NBCDs Non‐Biological Complex Drugs/Research | Posted 12/05/2017
Scientific and regulatory considerations for fo... Non‐Biological Complex Drugs/Research | Posted 05/05/2017
Equivalence of complex drug products Non‐Biological Complex Drugs/Reports | Posted 14/04/2017
Follow-up studies needed to ensure safety for f... Non‐Biological Complex Drugs/Research | Posted 31/03/2017
Warning letter causes delays for follow-on glat... Non‐Biological Complex Drugs/News | Posted 17/03/2017
Is the EU ready for non-biological complex drug... Non‐Biological Complex Drugs/Research | Posted 03/03/2017
Follow-on versions of glatiramer acetate in Rus... Non‐Biological Complex Drugs/News | Posted 24/02/2017
Non-biological complex drugs and pharmacopoeias Non‐Biological Complex Drugs/Research | Posted 10/02/2017
In vitro analysis of follow-on versions of seve... Non‐Biological Complex Drugs/Research | Posted 18/11/2016
Determining the bioequivalence of follow-on iro... Non‐Biological Complex Drugs/Reports | Posted 04/11/2016
FDA to set up abbreviated pathway for complex p... Non‐Biological Complex Drugs/Polices & Legislation | Posted 21/10/2016
Challenges in the assessment of ophthalmic emul... Non‐Biological Complex Drugs/Reports | Posted 07/10/2016
Cancer lab to evaluate bioequivalence of nanosi... Non‐Biological Complex Drugs/News | Posted 23/09/2016
A conference on ‘Equivalence of Complex Drug Pr... Non‐Biological Complex Drugs/News | Posted 09/09/2016
Collaboration to introduce nanotechnologies in... Non‐Biological Complex Drugs/News | Posted 26/08/2016
Iron carbohydrate follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 12/08/2016
Rigorous approach used to approve a follow-on v... Non‐Biological Complex Drugs/Research | Posted 29/07/2016
US guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 10/06/2016
Non-biological complex drugs and their follow-o... Non‐Biological Complex Drugs/Research | Posted 03/06/2016
Is a new pathway for NBCDs on the way in the US? Non‐Biological Complex Drugs/Polices & Legislation | Posted 27/05/2016
Follow-on glatiramer acetate gains European app... Non‐Biological Complex Drugs/News | Posted 13/05/2016
FDA includes follow-on versions in its new cycl... Non‐Biological Complex Drugs/Guidelines | Posted 29/04/2016
Switching between originator and follow-on iron... Non‐Biological Complex Drugs/Research | Posted 22/04/2016
Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015
more

Country Focus

All countries

Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!

Generics News Research General

more

Biosimilars News Research General

more

More editorial sections